SCHEMBL8548897

SCHEMBL8548897

CCOC(=O)/C=C/c1c(OC)c(=O)[nH]c2cc(Cl)ccc2c1=O

nearest known ligand 0.50

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 13/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8719187 1.00 ALOX15 (0.47) ALOX15
SCHEMBL8544547 0.89 ALOX15 (0.41) ALOX15
SCHEMBL8547075 0.87 ALOX15 (0.49) ALOX15
SCHEMBL8544259 0.86 TUBB4A (0.43) ALOX15
SCHEMBL8544261 0.86 TUBB4A (0.43) ALOX15
SCHEMBL7863130 0.85 PARP1 (0.38) ALOX15
SCHEMBL8929778 0.85 PARP1 (0.38) ALOX15
SCHEMBL8546080 0.83 PARP1 (0.41) ALOX15
SCHEMBL8546083 0.83 PARP1 (0.41) ALOX15
SCHEMBL8930082 0.80 MAPT (0.48) ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0702673-B1 BENZ(B)AZEPINE-2,5-DIONES USEFUL IN THE TREATMENT OF NEURODEGENERATIVE DISORDERS ZENECA LTD (GB) 1998-02-25 EP claimed
US-5801168-A NMDA RECEPTOR ANTAGONISTS ZENECA LIMITED (GB) 1998-09-01 US disclosed
US-5656626-A NERVOUS SYSTEM OR BRAIN DISORDERS; BENZ(B)AZEPINE ZENECA LIMITED (GB) 1997-08-12 US disclosed
EP-0702673-A1 BENZ(B)AZEPINE-2,5-DIONES USEFUL IN THE TREATMENT OF NEURODEGENERATIVE DISORDERS ZENECA LIMITED (GB) 1996-03-27 EP disclosed
WO-1994029275-A1 BENZ(B)AZEPINE-2,5-DIONES USEFUL IN THE TREATMENT OF NEURODEGENERATIVE DISORDERS ZENECA LIMITED (GB) 1994-12-22 WO disclosed